Chad M. Cohen
Chief Financial Officer, Zillow.
Companies
- GrindrBoard member Jun 5, 2025 to now1
- Vacasa, Inc.Board member Dec 7, 2021 to now2
- Adaptive BiotechnologiesChief financial officer Jun 26, 2019 to Dec 23, 20213
- TrupanionBoard member Dec 17, 2015 to Apr 3, 20194
- ZillowChief financial officer Feb 17, 2015 to Feb 20, 20155
- ZillowChief financial officer Jul 19, 2011 to Feb 17, 20156
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Adaptive Biotechnologies ADPT21,604 shares7$518.9K at $24.02Dec 22, 2021
Grindr GRND28,596 shares8$431.8K at $15.10Jun 2, 2026- Vacasa, Inc.0 shares9Apr 30, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 2, 2026Granted 4,049 shares of Grindr8
- Jun 2, 2026Granted 13,593 shares of Grindr8
- Nov 3, 2025Granted 221 shares of Grindr10
- Jul 30, 2025Granted 9,336 shares of Grindr11
- Jun 3, 2025Granted 1,397 shares of Grindr12
- Apr 30, 2025Returned to company 38,538 shares of Vacasa, Inc.9
- Apr 30, 2025Converted 8,158 shares of Vacasa, Inc.9
- Jul 30, 2024Granted 9,336 shares of Grindr13
- May 21, 2024Granted 20,134 shares of Vacasa, Inc.14
- May 23, 2023Granted 170,940 shares of Vacasa, Inc.15
- May 24, 2022Granted 33,999 shares of Vacasa, Inc.16
- Dec 22, 2021Sold 10,000 shares at $30.00 of Adaptive Biotechnologies7
- Dec 22, 2021Exercised options 10,000 shares at $7.27 of Adaptive Biotechnologies7
- Nov 10, 2021Sold 5,000 shares at $33.93 of Adaptive Biotechnologies17
- Nov 10, 2021Exercised options 5,000 shares at $7.27 of Adaptive Biotechnologies17
- Nov 9, 2021Sold 5,000 shares at $36.03 of Adaptive Biotechnologies17
- Nov 9, 2021Exercised options 5,000 shares at $7.27 of Adaptive Biotechnologies17
- Oct 6, 2021Sold 5,000 shares at $32.30 of Adaptive Biotechnologies18
- Oct 6, 2021Exercised options 5,000 shares at $7.27 of Adaptive Biotechnologies18
- Oct 5, 2021Sold 5,000 shares at $32.51 of Adaptive Biotechnologies18
- Oct 5, 2021Exercised options 5,000 shares at $7.27 of Adaptive Biotechnologies18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGrindr, Board member
- 2SEC EDGARVacasa, Inc., Board member
- 3
- 4SEC EDGARTrupanion, Board member
- 5SEC EDGARZillow, Chief financial officer
- 6SEC EDGARZillow, Chief financial officer
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Nov 5, 2025
- 11SEC EDGARForm 4 filed Aug 22, 2025
- 12SEC EDGARForm 4 filed Jun 5, 2025
- 13SEC EDGARForm 4 filed Aug 1, 2025
- 14SEC EDGARForm 4 filed May 23, 2024
- 15SEC EDGARForm 4 filed May 24, 2023
- 16SEC EDGARForm 4 filed May 25, 2022
- 17SEC EDGARForm 4 filed Nov 12, 2021
- 18SEC EDGARForm 4 filed Oct 7, 2021